BioWorld Science

Feb. 12, 2018

View Archived Issues

Cellenkos manufacturing facility is successfully registered as GMP compliant with the FDA

Read More

Acesion Pharma cleared to conduct phase I study of AP-30663

Read More

Janssen submits MAA to EMA for apalutamide for nonmetastatic CRPC

Read More

Phase II trials of BI-409306 in Alzheimer's disease do not meet efficacy endpoints

Read More

Novo Nordisk's Ozempic approved in E.U.

Read More

Boehringer Ingelheim initiates phase I study of BI-1291583

Read More

Aravive studies AVB-S6-500 in healthy volunteers

Read More

Lundbeck updates progress of fourth quarter 2017

Read More

Tychan initiates phase Ia trial of first-in-class Zika antibody tyzivumab

Read More

Puma presents clinical data on neratinib in patients with HER2/3 mutant cancers

Read More

Phase III quality of life data reported for turoctocog alfa pegol in hemophilia A

Read More

Kissei presents novel CGRP antagonists

Read More

Retrophin divulges new pantetheine derivatives for neurodegeneration

Read More

New phase I/II trial evaluates lentiviral gene transfer for SCID-X1

Read More

Achaogen discloses novel ACC inhibitors for bacterial infections

Read More

Novel USP19 inhibitors presented by Almac Discovery

Read More

Toray Industries identifies MALT1 inhibitors

Read More

Roivant and Poxel sign development and license agreement for imeglimin

Read More

Seattle Genetics and Pieris Pharmaceuticals enter immune-oncology collaboration

Read More

Scholar Rock's SRK-015 antibody inhibits muscle wasting by binding myostatin precursors

Read More